SEC 13F Intelligence

Equitec Proprietary Markets, LLC / ITCIEUR

Equitec Proprietary Markets, LLC’s Intra-Cellular Therapies Inc Position

Does Equitec Proprietary Markets, LLC own Intra-Cellular Therapies Inc (ITCIEUR)? Not currently — the last reported position was 55.1K shares worth $7M in Q1 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$7M
Q1 2025
Shares
55.1K
% of Portfolio
+5.17%
Quarters Held
1
position exited

Position History ITCIEUR

Reported value by quarter
Q1 ’25: $7MQ1 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202555.1K$7M+5.17%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Equitec Proprietary Markets, LLC’s full portfolio or all institutional holders of ITCIEUR.